Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Trad R, Warda W, Alcazer V, Neto da Rocha M, Berceanu A, Nicod C, Haderbache R, Roussel X, Desbrosses Y, Daguindau E, Renosi F, Roumier C, Bouquet L, Biichle S, Guiot M, Seffar E, Caillot D, Depil S, Robinet E, Salma Y, Deconinck E, Deschamps M, Ferrand C. Trad R, et al. Among authors: alcazer v. J Immunother Cancer. 2022 Jul;10(7):e004222. doi: 10.1136/jitc-2021-004222. J Immunother Cancer. 2022. PMID: 35803613 Free PMC article.
Nouvelles approches vaccinales en cancérologie.
Depil S, Bonaventura P, Alcazer V, Tonon L. Depil S, et al. Among authors: alcazer v. Bull Cancer. 2018 Dec;105 Suppl 1:S113-S120. doi: 10.1016/S0007-4551(18)30396-5. Bull Cancer. 2018. PMID: 30595192 Review. French.
Neoepitopes-based vaccines: challenges and perspectives.
Alcazer V, Bonaventura P, Tonon L, Wittmann S, Caux C, Depil S. Alcazer V, et al. Eur J Cancer. 2019 Feb;108:55-60. doi: 10.1016/j.ejca.2018.12.011. Epub 2019 Jan 12. Eur J Cancer. 2019. PMID: 30648630
Développement des CAR-T dans les tumeurs solides.
Alcazer V, Delenda C, Poirot L, Depil S. Alcazer V, et al. Bull Cancer. 2018 Dec;105 Suppl 2:S178-S187. doi: 10.1016/S0007-4551(19)30048-7. Bull Cancer. 2018. PMID: 30686356 Review. French.
Cold Tumors: A Therapeutic Challenge for Immunotherapy.
Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S. Bonaventura P, et al. Among authors: alcazer v. Front Immunol. 2019 Feb 8;10:168. doi: 10.3389/fimmu.2019.00168. eCollection 2019. Front Immunol. 2019. PMID: 30800125 Free PMC article. Review.
Cancer vaccines: what's next?
Depil S, Bonaventura P, Alcazer V. Depil S, et al. Among authors: alcazer v. Oncotarget. 2019 Jun 18;10(40):3985-3987. doi: 10.18632/oncotarget.27006. eCollection 2019 Jun 18. Oncotarget. 2019. PMID: 31258838 Free PMC article. No abstract available.
[Development of allogeneic CAR T-cells].
Alcazer V, Depil S. Alcazer V, et al. Bull Cancer. 2021 Oct;108(10S):S73-S80. doi: 10.1016/j.bulcan.2021.01.025. Bull Cancer. 2021. PMID: 34920810 Review. French.
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy.
Alcazer V, Bonaventura P, Tonon L, Michel E, Mutez V, Fabres C, Chuvin N, Boulos R, Estornes Y, Maguer-Satta V, Geistlich K, Viari A, Metzeler KH, Hiddemann W, Batch AMN, Herold T, Caux C, Depil S. Alcazer V, et al. Am J Hematol. 2022 Sep;97(9):1200-1214. doi: 10.1002/ajh.26647. Epub 2022 Jul 12. Am J Hematol. 2022. PMID: 35759575 Free PMC article.
36 results